Clene Nanomedicine Employee Directory

Clene Nanomedicine corporate office is located in 6550 S Millrock Dr Ste G50, Salt Lake City, Utah, 84121, United States and has 51-200 employees.

Employees by Department

Departments

Number of employees

Operations

18

Engineering & Technical

13

Medical & Health

4

Finance

3

Legal

2

Human Resources

1

Key Employees of Clene Nanomedicine

  • Mark Mortenson, Co-Founder & Chief Technology Officer at Clene Nanomedicine
    United States flag for contact location.
    Mark Mortenson

    Co-Founder & Chief Technology Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Clene Nanomedicine Global Presence

globalPresence illustration
North America11-50

Index of contact profiles from Clene Nanomedicine

Hundreds of professionals searching for Clene Nanomedicine have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
123

Former Employees at Clene Nanomedicine

Explore people who held key positions, contributed to Clene Nanomedicine's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Utah, United States

Frequently Asked Questions Regarding Clene Nanomedicine Employees

How many employees does Clene Nanomedicine have?
Clene Nanomedicine has 51-200 employees
Who is the CFO of Clene Nanomedicine?
Clene Nanomedicine’s CFO is Morgan Brown
Who are Clene Nanomedicine key employees?
Some of Clene Nanomedicine key employees are Mark Mortenson
Where is Clene Nanomedicine located?
Clene Nanomedicine’s headquarters are located at 6550 S Millrock Dr Ste G50, Salt Lake City, Utah, 84121, United States
How do I contact Clene Nanomedicine?
Clene Nanomedicine Contact Info: Phone number: (801) 676-9695 Website: www.clene.com
What does Clene Nanomedicine do?

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au... 8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis.Read More

Is Clene Nanomedicine a public company?
Yes, Clene Nanomedicine is a public company and is traded under the symbol CLNN
See more information about Clene Nanomedicine Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.